4//SEC Filing
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 4
Accession 0000950170-23-048874
CIK 0001825367other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 7:41 PM ET
Size
7.0 KB
Accession
0000950170-23-048874
Insider Transaction Report
Form 4
RayzeBio, Inc.RYZB
Transactions
- Conversion
Common Stock
2023-09-19+1,557,846→ 1,557,846 total - Conversion
Series D Preferred Stock
2023-09-19−1,557,846→ 0 total→ Common Stock (1,557,846 underlying)
Footnotes (1)
- [F1]Upon the closing of the Issuer's initial public offering, each share of Series D Preferred Stock automatically converted into one share of the Issuer's Common Stock. The Series D Preferred Stock had no expiration date.
Documents
Issuer
RayzeBio, Inc.
CIK 0001825367
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001903360
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 7:41 PM ET
- Size
- 7.0 KB